BioVie to announce topline data from Phase 3 Alzheimer's Disease trial by year-end

BioVie Inc (NASDAQ:BIVI) said the last patient has completed their final visit at week 30 in their Phase 3 study of investigational therapy NE3107 in...

Related Keywords

,Joseph Palumbo ,Ad Cooperative Study ,Drug Administration ,Biovie Inc ,Scale Cognitive ,Study Clinical Global Impression ,Statistical Analysis Plan ,